コンテンツへスキップ
Merck
すべての画像(2)

Key Documents

912298

Sigma-Aldrich

NanoFabTx microfluidic chip

for 10-30 μm particles

別名:

Microfluidic kit, Microparticle, NanoFabTx, Nanoformulation

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
41121800
NACRES:
NA.23

詳細

Microfludic hardware kit component for synthesizing 10-30 μm microparticles

Kit components : Microfluidic chip x 1

品質水準

アプリケーション

advanced drug delivery

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

NanoFabTx microfluidic chip, for 10-30 μm particles is a component of our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

アプリケーション

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx microfluidic chip, for 10-30 μm particles particles can be used as a replacement for the component in our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879).

法的情報

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

申し訳ございませんが、現在この製品のCOAをオンラインで入手できません。

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)